BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Treg donor cells: Phase I/II data

Researchers at the university and colleagues reported data from a Phase I/II trial in 28 patients with high-risk hematological malignancies who received an infusion of donor Treg cells 4 days before HSCT, followed by an infusion of...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >